Skip to search formSkip to main contentSkip to account menu

CS 622

Known as: CS-622, CS622 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

temocapril hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Single dose pharmacokinetics of temocapril (CS-622), a novel angiotensin converting enzyme (ACE) inhibitor, in partially nephrectomized rats
1991
1991
Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay.
1991
1991
Mutagenicity studies of temocapril hydrochloride (CS-622)
1991
1991
第11回日本臨床薬理学会記録 一般演題 本態性高血圧症における運動負荷時の血行動態・血漿ノルエピネフリンに及ぼすアンジオテンシン変換酵素阻害薬 (CS-622) の影響
1990
1990
EFFECTS OF CHRONIC CONVERTING ENZYME INHIBITION ON THE VASCULAR RENIN‐ANGIOTENSIN SYSTEM
1. The effects of chronic oral administration of inhibitors of angiotensin converting enzyme (ACE) on the vascular renin… 
1989
1989
Determination of a new angiotensin-converting enzyme inhibitor (CS-622) and its active metabolite in plasma and urine by gas chromatography-mass spectrometry using negative ion chemical ionization.
1988
1988
Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR).
1988
1988
145 Long‐term administration of CS‐622, a novel angiotensin converting enzyme inhibitor, alters Ca2+ permeability of the aorta in the spontaneously hypertensive rat
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)